Lin BioScience (ROCO:6696) Short-Term Capital Lease Obligation : NT$13.48 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Short-Term Capital Lease Obligation?

Lin BioScience's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was NT$13.48 Mil.

Lin BioScience's quarterly Short-Term Capital Lease Obligation increased from Jun. 2022 (NT$8.50 Mil) to Dec. 2022 (NT$10.32 Mil) and increased from Dec. 2022 (NT$10.32 Mil) to Jun. 2023 (NT$13.48 Mil).

Lin BioScience's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (NT$2.24 Mil) to Dec. 2022 (NT$10.32 Mil) and increased from Dec. 2022 (NT$10.32 Mil) to Dec. 2023 (NT$13.85 Mil).

Lin BioScience Short-Term Capital Lease Obligation Historical Data

The historical data trend for Lin BioScience's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Short-Term Capital Lease Obligation Chart

Lin BioScience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.83

2.91

2.24

10.32

13.85

Lin BioScience Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										2.24	8.50	10.32	13.48	13.85

Lin BioScience Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Lin BioScience Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Lin BioScience's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience (ROCO:6696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110

Website

https://www.linbioscience.com

Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines